DOAC in Unusual Site Venous Thrombosis (DUST)
International Registry on the Use of the Direct Oral Anticoagulants for the Treatment of Unusual Site Venous Thromboembolism
Sponsor: University of Malta
Listed as NCT03778502, this observational or N/A phase trial focuses on Cerebral Vein Thrombosis and Ovarian Vein Thrombosis and remains completed. Sponsored by University of Malta, it has been updated 11 times since 2019, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Aug 2025 — Sep 2025 [monthly]
Completed
Status: Unknown → Completed
-
May 2025 — Aug 2025 [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2024 — May 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
▶ Show 6 earlier versions
-
May 2023 — Jul 2024 [monthly]
Recruiting
Status: Unknown Status → Recruiting
-
Feb 2023 — May 2023 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jan 2021 — Feb 2023 [monthly]
Recruiting
-
Jun 2020 — Jan 2021 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jun 2019 — Jun 2020 [monthly]
Not Yet Recruiting
-
Jan 2019 — Jun 2019 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Malta
- Università degli Studi dell'Insubria
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Amiens, France , Bangkok, Thailand , Bologna, Italy , Brest, France , Como, Italy , Detroit, United States , Genova, Italy , Ljubljana, Slovenia , Lyon, France , Madrid, Spain and 11 more locations